Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  
Services
Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks
Mendeley

Cite by
Google Scholar



Article History
Submitted: 26 Apr 2016
Revised: 05 Sep 2016
Accepted: 19 Sep 2016
First published online: 22 Dec 2016

Article Access Statistics
Abstract Page Views: 280
PDF Downloads: 202
Full Text Views: 0

Adv Pharm Bull. 2016;6(4):541-549 doi: 10.15171/apb.2016.068

Acute and Subchronic Toxicity Study of the Median Septum of Juglans regia in Wistar Rats

Research Article

Asma Ravanbakhsh 1, Majid Mahdavi 2 * , Ghader Jalilzade-Amin 2, Shahram Javadi 2, Masoud Maham 2, Daryosh Mohammadnejad 3, Mohammad Reza Rashidi 4 *

1 Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran.
2 Department of Clinical Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
3 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
4 School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.



Abstract
Purpose: Median septum of Juglans regia L. (Juglandaceae) with anti-diabetic effects has been used in Iranian traditional medicine. The present study estimates both oral acute and subchronic toxicities. Methods: In the oral acute toxicity study, female Wistar rats were treated with doses of 10, 100, 1000, 1600, 2900 and 5000 mg/ kg of the Juglans regia septum of methanol extract (JRSME), and were monitored for 14 days. In subchronic study, JRSME was administered by gavage at dose of 1000 mg/kg daily in Wistar rats for 28 days. Antioxidant status and biochemical examinations were fulfilled, and the vital organs were subjected to pathological analyses. Results: The extract did not produce any toxic signs or deaths; the medium lethal dose must be higher than 5000 mg/kg. In subchronic study, No significant morphological and histopathological changes were observed in the studied tissues. There was a significant increase in serum malondialdehyde (MDA) level in treated group compared to control after 4 weeks of JRSME intake. The treatment of rats resulted in a significant reduction of serum urea level (p<0.05), kidney’s xanthine dehydrogenase (XDH) activity (p<0.001) and elevation of aldehyde oxidase (AO) activity (p<0.05) in kidney. In the treated group, the mean diameter of glomerulus and proximal urine tube epithelium stature was slightly greater than control group. A significant increase in serum MDA level is subject for further studies. Conclusion: This study showed that the extract has no acute or subacute adverse effects with dose of 1000 mg/kg. The administration of JRSME may improve kidney structure and function and help in treatment of some chronic diseases.





Comments
First name  
Last name  
Email address  
Comments  
Security code



This Article
PDF

Google Scholar
Articles by Ravanbakhsh A
Articles by Mahdavi M
Articles by Jalilzade-Amin G
Articles by Javadi S
Articles by Maham M
Articles by Mohammadnejad D
Articles by Rashidi MR

PubMed
Articles by Ravanbakhsh A
Articles by Mahdavi M
Articles by Jalilzade-Amin G
Articles by Javadi S
Articles by Maham M
Articles by Mohammadnejad D
Articles by Rashidi MR



Share this article!

Press Manuscript Online. Powered by MAADRAYAN